The role of phosphorylation on the structure and dynamics of phospholamban: A model from molecular simulations

Proteins: Structure, Function and Genetics

Volumn 66, Issue 4, 2007, Pages 930-940

  Pantano, Sergio ^a,b   Carafoli, Ernesto ^a  

^a VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^b UNIVERSIDAD NACIONAL DE SAN LUIS   (Argentina)

Author keywords

ATP ase; Calcium pump; Inhibition; Membrane protein; Regulation; SERCA

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); MEMBRANE PROTEIN; PHOSPHOLAMBAN;

ARTICLE; CALCIUM TRANSPORT; HYDROGEN BOND; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SARCOPLASMIC RETICULUM;

ASPARAGINE; CALCIUM-BINDING PROTEINS; COMPUTER SIMULATION; CYTOPLASM; HYDROGEN BONDING; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SERINE; WATER;

EID: 33847025691     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21239     Document Type: Article

References (64)

1. Tada M, Kirchberger MA, Repke DI, Katz AM. The stimulation of calcium transport in cardiac sarcoplasmic reticulum by adenosine 3′:5′- monophosphate-dependent protein kinase. J Biol Chem 1974;249:6174-6180.
2. Simmerman HK, Jones LR. Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev 1998;78:921-947.
3. Kirchberger MA, Tada M, Katz AM. Phospholamban: a regulatory protein of the cardiac sarcoplasmic reticulum. Recent Adv Stud Cardiac Struct Metab 1975;5:103-115.
4. Katz AM, Tada M, Kirchberger MA. Control of calcium transport in the myocardium by the cyclic AMP-Protein kinase system. Adv Cyclic Nucleotide Res 1975;5:453-472.
5. Fujii J, Maruyama K, Tada M, MacLennan DH. Expression and site-specific mutagenesis of phospholamban. Studies of residues involved in phosphorylation and pentamer formation. J Biol Chem 1989;264:12950-12955.
6. Mattiazzi A, Mundina-Weilenmann C, Guoxiang C, Vittone L, Kranias E. Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions. Cardiovasc Res 2005;68:366-375.
7. Brittsan AG, Kranias EG. Phospholamban and cardiac contractile function. J Mol Cell Cardiol 2000;32:2131-2139.
8. MacLennan DH, Kranias EG. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 2003;4:566-577.
9. Haghighi K, Gregory KN, Kranias EG. Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy. Biochem Biophys Res Commun 2004;322:1214-1222.
10. Lamberth S, Scmid H, Muenchbach M, Vorherr T, Krebs J, Carafoli E, Griesinger C. NMR solution structure of phospholamban. Helv Chim Acta 2000;83:2141-2152.
11. Maslennikov IV, Sobol AG, Anagli J, James P, Vorherr T, Arseniev AS, Carafoli E. The secondary structure of phospholamban: a two-dimensional NMR study. Biochem Biophys Res Commun 1995;217:1200-1207.
12. Pollesello P, Annila A, Ovaska M. Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer. Biophys J 1999;76:1784-1795.
13. Zamoon J, Mascioni A, Thomas DD, Veglia G. NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles. Biophys J 2003;85:2589-2598.
14. Karim CB, Kirby TL, Zhang Z, Nesmelov Y, Thomas DD. Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone. Proc Natl Acad Sci USA 2004;101:14437-14442.
15. Metcalfe EE, Zamoon J, Thomas DD, Veglia G. (1)H/(15)N heteronuclear NMR spectroscopy shows four dynamic domains for phospholamban reconstituted in dodecylphosphocholine micelles. Biophys J 2004;87:1205-1214.
16. Zamoon J, Nitu F, Karim C, Thomas DD, Veglia G. Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phospholamban in calcium pump regulation. Proc Natl Acad Sci USA 2005;102:4747-4752.
17. Houndonougbo Y, Kuczera K, Jas GS. Structure and dynamics of phospholamban in solution and in membrane bilayer: computer simulations. Biochemistry 2005;44:1780-1792.
18. Paterlini MG, Thomas DD. The α-helical propensity of the cytoplasmic domain of phospholamban: a molecular dynamics simulation of the effect of phosphorylation and mutation. Biophys J 2005;88:3243-3251.
19. Tatulian SA, Jones LR, Reddy LG, Stokes DL, Tamm LK. Secondary structure and orientation of phospholamban reconstituted in supported bilayers from polarized attenuated total reflection FTIR spectroscopy. Biochemistry 1995;34:4448-4456.
20. 2+ pump of sarcoplasmic reticulum. Nature 1989;342:90-92.
21. del Monte F, Harding SE, Dec GW, Gwathmey JK, Hajjar RJ. Targeting phospholamban by gene transfer in human heart failure. Circulation 2002;105:904-907.
22. del Monte F, Williams E, Lebeche D, Schmidt U, Rosenzweig A, Gwathmey JK, Lewandowski ED, Hajjar RJ. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure. Circulation 2001;104:1424-1429.
23. 2+ pump revealed with use of heterobifunctional cross-linking agents. J Biol Chem 2003;278:48348- 48356.
24. 2+ pump of cardiac sarcoplasmic reticulum. J Biol Chem 2005;280:10530-10539.
25. Oxenoid K, Chou JJ. The structure of phospholamban pentamer reveals a channel-like architecture in membranes. Proc Natl Acad Sci USA 2005;102:10870-10875.
26. Li M, Reddy LG, Bennett R, Silva ND, Jr, Jones LR, Thomas DD. A fluorescence energy transfer method for analyzing protein oligomeric structure: application to phospholamban. Biophys J 1999;76:2587-2599.
27. Reddy LG, Jones LR, Thomas DD. Depolymerization of phospholamban in the presence of calcium pump: a fluorescence energy transfer study. Biochemistry 1999;38:3954-3962.
28. Reddy LG, Autry JM, Jones LR, Thomas DD. Co-reconstitution of phospholamban mutants with the Ca-ATPase reveals dependence of inhibitory function on phospholamban structure. J Biol Chem 1999;274:7649-7655.
29. 2+ pump of cardiac sarcoplasmic reticulum. J Biol Chem 2000;275:41487-41494.
30. Thomas DD, Reddy LG, Karim CB, Li M, Cornea R, Autry JM, Jones LR, Stamm J. Direct spectroscopic detection of molecular dynamics and interactions of the calcium pump and phospholamban. Ann NY Acad Sci 1998;853:186-194.
31. 2+-ATPaSe isoform of cardiac sarcoplasmic reticulum. J Biol Chem 1998;273:14238-14241.
32. Kimura Y, Kurzydlowski K, Tada M, MacLennan DH. Phospholamban inhibitory function is activated by depolymerization. J Biol Chem 1997;272:15061-15064.
33. 2+-ATPaSe through intramembrane interactions. J Biol Chem 1996;271:21726-21731.
34. 2+ pump ATPase. J Biol Chem 1992;267:1674-1679.
35. Kirby TL, Karim CB, Thomas DD. Electron paramagnetic resonance reveals a large-scale conformational change in the cytoplasmic domain of phospholamban upon binding to the sarcoplasmic reticulum Ca-ATPase. Biochemistry 2004;43:5842-5852.
36. Hidalgo C, Ikemoto N, Gergely J. Role of phospholipids in the calcium-dependent ATPase of the sarcoplasmic reticulum. Enzymatic and ESR studies with phospholipid-replaced membranes. J Biol Chem 1976;251:4224-4232.
37. Szymanska G, Kim HW, Kranias EG. Reconstitution of the skeletal sarcoplasmic reticulum Ca2(+)-pump: influence of negatively charged phospholipids. Biochim Biophys Acta 1991;1091:127-134.
38. Meissner G, Fleischer S. Characterization of sarcoplasmic reticulum from skeletal muscle. Biochim Biophys Acta 1971;241:356-378.
39. Cornell WD et al. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J Am Chem Soc 1995;117:5179-5197.
40. Jorgensen W, Chandrasekhar J, Madura J, Klein M. Comparison of simple potential functions for simulating liquid water. J Chem Phys 1983;79:926-935.
41. Wang W, Donini O, Reyes CM, Kollman PA. Biomolecular simulations: recent developments in force fields, simulations of enzyme catalysis, protein-ligand, protein-protein, and protein-nucleic acid noncovalent interactions. Annu Rev Biophys Biomol Struct 2001;30:211-243.
42. Homeyer N, Horn AH, Lanig H, Sticht H. AMBER force-field parameters for phosphorylated amino acids in different protonation states: phosphoserine, phosphothreonine, phosphotyrosine, and phosphohistidine. J Mol Model (Online) 2006;12:281-289.
43. 2+ di-nuclear ion centers in the active site. Comput Chem 2000;24:381-390.
44. Tieleman DP, Marrink SJ, Berendsen HJ. A computer perspective of membranes: molecular dynamics studies of lipid bilayer systems. Biochim Biophys Acta 1997;1331:235-270.
45. Moore PB, Lopez CF, Klein ML. Dynamical properties of a hydrated lipid bilayer from a multinanosecond molecular dynamics simulation. Biophys J 2001;81:2484-2494.
46. Case DA, Darden TA, Cheatham III, TE, Simmerling CL, Wang J, Duke RE, Lou R, Merz KM, Wang B, Pearlman DA, Crowley M, Brozell S, Tsui V, Gohlke H, Mongan J, Hornak V, Cui G, Beroza P, Schafmeister C, Caldwell JW, Ross WS, Kollman PA. AMBER 8.0. Amber 2004.
47. Darden TA, York D. Particle Mesh Ewald: an N log(N) method for Ewald sums in large systems. J Chem Phys 1993;98:10089-10094.
48. Ryckaert JP, Ciccotti G, Berendsen HJ. Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n- Alkanes. J Comput Phys 1977;23:327-341.
49. Berendsen HJ, Postma JPM, van Gunsteren WFDA, Haak JR. Molecular dynamics with coupling to an external bath. J Chem Phys 1984;81:3684-3690.
50. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996;14:33-38.
51. Mascioni A, Karim C, Zamoon J, Thomas DD, Veglia G. Solid-state NMR and rigid body molecular dynamics to determine domain orientations of monomeric phospholamban. J Am Chem Soc 2002;124:9392-9393.
52. Metcalfe EE, Traaseth NJ, Veglia G. Serine 16 phosphorylation induces an order-to-disorder transition in monomeric phospholamban. Biochemistry 2005;44:4386-4396.
53. Li J, Boschek CB, Xiong Y, Sacksteder CA, Squier TC, Bigelow DJ. Essential role for Pro21 in phospholamban for optimal inhiition of the Ca-ATPase. Biochemistry 2005;44:16181-16191.
54. Haghighi K et al. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc Natl Acad Sci USA 2006;103:1388-1393.
55. Li J, Bigelow DJ, Squier TC. Conformational changes within the cytosolic portion of phospholamban upon release of Ca-ATPase inhibition. Biochemistry 2004;43:3870-3879.
56. Hubbard JA et al. Conformation of the cytoplasmic domain of phospholamban by NMR and CD. Mol Membr Biol 1994;11:263-269.
57. Mortishire-Smith RJ, Pitzenberger SM, Burke CJ, Middaugh CR, Garsky VM, Johnson RG. Solution structure of the cytoplasmic domain of phopholamban: phosphorylation leads to a local perturbation in secondary structure. Biochemistry 1995;34:7603-7613.
58. 2+ pump revealed by intermolecular thiol cross-linking. J Biol Chem 2002;277:28319-28329.
59. Cornea RL, Jones LR, Autry JM, Thomas DD. Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers. Biochemistry 1997;36:2960-2967.
60. Traaseth NJ, Thomas DD, Veglia G. Effects of Ser16 phosphorylation on the allosteric transitions of phospholamban/Ca(2+)-ATPase complex. J Mol Biol 2006;358:1041-1050.
61. Toyofuku T, Kurzydlowski K, Tada M, MacLennan DH. Identification of regions in the Ca(2+)-ATPase of sarcoplasmic reticulum that affect functional association with phospholamban. J Biol Chem 1993;268:2809-2815.
62. 2+ ATPase. Proc Natl Acad Sci USA 2003;100:467-472.
63. Herbette L et al. Phospholipid asymmetry in the isolated sarcoplasmic reticulum membrane. Arch Biochem Biophys 1984;234:235-242.
64. Chiesi M, Schwaller R. Involvement of electrostatic phenomena in phospholamban-induced stimulation of Ca uptake into cardiac sarcoplasmic reticulum. FEBS Lett 1989;244:241-244.